<doc>
  <docmeta id="113hres91ih">
    <bill congress="113" type="hres" number="91" version="ih"/>
    <revision size="3519" annotations="0" id="7" commit-time="2013-04-13T19:15:03+00:00" committer="favila" doc="113hres91ih/7.xml" status="complete">
      <description>Edited via AKN</description>
    </revision>
  </docmeta>
  <resolution xmlns:cato="http://namespaces.cato.org/catoxml" dms-id="HB202E2F34E084DE5BEAF497032D75DD5" public-private="public" resolution-stage="Introduced-in-House" resolution-type="house-resolution" star-print="no-star-print" key="H"> 
<form> 
<distribution-code display="yes">IV</distribution-code> 
<congress display="yes">113th CONGRESS</congress>
<session display="yes">1st Session</session>
<legis-num>H. RES. 91</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action display="yes"> 
<action-date date="20130228">February 28, 2013</action-date> 
<action-desc>
        <sponsor name-id="C001072">Mr. Carson of Indiana</sponsor> (for himself, <cosponsor name-id="B001248">Mr. Burgess</cosponsor>, <cosponsor name-id="C001090">Mr. Cartwright</cosponsor>, <cosponsor name-id="C001075">Mr. Cassidy</cosponsor>, <cosponsor name-id="C000380">Mrs. Christensen</cosponsor>, <cosponsor name-id="C000714">Mr. Conyers</cosponsor>, <cosponsor name-id="C001038">Mr. Crowley</cosponsor>, <cosponsor name-id="H001032">Mr. Holt</cosponsor>, <cosponsor name-id="L000567">Mr. Lance</cosponsor>, <cosponsor name-id="L000551">Ms. Lee of California</cosponsor>, <cosponsor name-id="L000263">Mr. Levin</cosponsor>, <cosponsor name-id="N000147">Ms. Norton</cosponsor>, <cosponsor name-id="S001175">Ms. Speier</cosponsor>, and <cosponsor name-id="W000797">Ms. Wasserman Schultz</cosponsor>) submitted the following resolution; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>
      </action-desc>
</action> 
<legis-type>RESOLUTION</legis-type> 
<official-title display="yes">Expressing support for designation of February 28, 2013, as Rare Disease Day.</official-title> 
</form>
<preamble>
<whereas>
      <text>Whereas rare diseases and disorders are those which affect small patient populations, typically populations smaller than 200,000 people in the United States;</text>
    </whereas>
<whereas>
      <text>Whereas nearly 7,000 rare diseases affect 30,000,000 people in the United States and their families;</text>
    </whereas>
<whereas>
      <text>Whereas children with rare genetic diseases account for more than half of the population affected by rare diseases in the United States;</text>
    </whereas>
<whereas>
      <text>Whereas many rare diseases are serious, life-threatening, and lack an effective treatment;</text>
    </whereas>
<whereas>
      <text>Whereas rare diseases and conditions include epidermolysis bullosa, progeria, sickle cell anemia, Tay-Sachs, cystic fibrosis, many childhood cancers, and fibrodysplasia ossificans progressiva;</text>
    </whereas>
<whereas>
      <text>Whereas people with rare diseases experience challenges that include difficulty in obtaining an accurate diagnosis, limited treatment options, and difficulty finding physicians or treatment centers with expertise in their disease;</text>
    </whereas>
<whereas>
      <text>Whereas great strides have been made in research and treatment for rare diseases as a result of the <cato:entity-ref entity-type="act" value="Orphan Drug Act">Orphan Drug Act</cato:entity-ref>;</text>
    </whereas>
<whereas>
      <text>Whereas 2013 marks the 30th anniversary of the <cato:entity-ref entity-type="act" value="Orphan Drug Act">Orphan Drug Act</cato:entity-ref> and therefore a time to reflect upon its successes to date and challenges to be addressed in the future;</text>
    </whereas>
<whereas>
      <text>Whereas both the <cato:entity-ref entity-type="federal-body" entity-id="7524">Food and Drug Administration</cato:entity-ref> and the <cato:entity-ref entity-type="federal-body" entity-id="7529">National Institutes of Health</cato:entity-ref> have established special offices to advocate for rare disease research and treatments;</text>
    </whereas>
<whereas>
      <text>Whereas the National Organization for Rare Disorders, an organization established in 1983 to provide services to, and advocate on behalf of, patients with rare diseases, was a primary force behind the enactment of the <cato:entity-ref entity-type="act" value="Orphan Drug Act">Orphan Drug Act</cato:entity-ref> and remains a critical public voice for people with rare diseases;</text>
    </whereas>
<whereas>
      <text>Whereas the National Organization for Rare Disorders sponsors Rare Disease Day in the United States to increase public awareness of rare diseases;</text>
    </whereas>
<whereas>
      <text>Whereas Rare Disease Day has become a global event occurring annually on the last day of February and observed in more than 60 countries in 2012;</text>
    </whereas>
<whereas>
      <text>Whereas Rare Disease Day was observed in the United States for the first time on February 28, 2009;</text>
    </whereas>
<whereas>
      <text>Whereas February 28, 2013, would be an appropriate date to designate as Rare Disease Day; and</text>
    </whereas>
<whereas>
      <text>Whereas Rare Disease Day is anticipated to be observed globally in years to come, providing hope and information for rare disease patients around the world: Now, therefore, be it</text>
    </whereas>
  </preamble> 
<resolution-body style="traditional" id="H1612C87309BA40B9AF92FFB979DFF67F"> 
<section display-inline="yes-display-inline" section-type="undesignated-section" id="H1DEE5EC10BA24ECDAB6851315574126F">
      <text>That the <cato:entity-ref entity-type="federal-body" entity-id="0050">House of Representatives</cato:entity-ref>â€”</text>
<paragraph id="H8E3549E33DA645DEAE1303C7D5947A72">
        <enum>(1)</enum>
        <text display-inline="yes-display-inline">supports the designation of Rare Disease Day;</text>
      </paragraph>
<paragraph id="H629F6AB3719C41D9BEC8E84F8FE0DACA">
        <enum>(2)</enum>
        <text display-inline="yes-display-inline">recognizes the importance of improving awareness and encouraging accurate and early diagnosis of rare diseases and disorders; and</text>
      </paragraph>
<paragraph id="HC088E52639FF4A699EF0CD84B71774CE">
        <enum>(3)</enum>
        <text>supports a national and global commitment to improving access to, and developing new treatments, diagnostics, and cures for, rare diseases and disorders.</text>
      </paragraph>
    </section> 
</resolution-body> 
</resolution>
</doc>